Infinity Pharmaceuticals | INFI - Ebitda


Infinity Pharmaceuticals reported $-10.01M in EBITDA for its fiscal quarter ending in June of 2023.





Ebitda Change Date
AbbVie USD 5.37B 1.85B Dec/2025
Alterity Therapeutics Limited AUD -7.72M 2.99M Jun/2023
Amgen USD 5.14B 775M Dec/2025
AstraZeneca USD 5.67B 1.29B Mar/2026
Bristol-Myers Squibb USD 2.88B 1.36B Dec/2025
Cipla INR 12.55B 6.4B Dec/2025
Clal Biotechnology ILS -5.3M 2.09M Dec/2022
Compugen USD -7.89M 536K Sep/2025
CSL USD 3.13B 1.17B Dec/2025
Eisai JPY 30.1B 6.62B Dec/2025
Eli Lilly USD 12.14B 4.26B Dec/2025
Gilead Sciences USD 3.02B 1.01B Dec/2025
GlaxoSmithKline GBP 2.77B 1.65B Mar/2026
Grifols EUR 482.04M 7.04M Sep/2025
Incyte USD 367.97M 46.53M Mar/2026
Infinity Pharmaceuticals USD -10.01M 1.39M Jun/2023
Ionis Pharmaceuticals USD -200.02M 42.89M Dec/2025
J&J USD 7.19B 2.32B Dec/2025
Novartis USD 5.3B 530M Mar/2026
Pfizer USD 5.99B 5.23B Mar/2026
Plus Therapeutics USD -4.4M 2.94M Sep/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
TG Therapeutics USD 51.69M 19M Dec/2025